Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang, Jian Shang, Shibo Jiang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 416

Showing 26-50 of 416 citing articles:

Polymeric nanoparticle vaccines to combat emerging and pandemic threats
David Wibowo, Sytze H.T. Jorritsma, Zennia Jean Gonzaga, et al.
Biomaterials (2020) Vol. 268, pp. 120597-120597
Open Access | Times Cited: 135
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 131
Integrated gut virome and bacteriome dynamics in COVID-19 patients
Yīmíng Bào, Cheng Wang, Yuqing Zhang, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 123
The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis
Nicholas A. Wong, Milton H. Saier
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1308-1308
Open Access | Times Cited: 119
Neutralizing antibodies for the prevention and treatment of COVID-19
Lanying Du, Yang Yang, Xiujuan Zhang
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2293-2306
Open Access | Times Cited: 117
SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
Yang Yang, Lanying Du
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 114
Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 59
Combatting Salmonella: a focus on antimicrobial resistance and the need for effective vaccination
Junaid Nazir, Tasaduq Manzoor, Afnan Saleem, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 3
SARS-CoV-2 Vaccine Development: Current Status
Gregory A. Poland, Inna G. Ovsyannikova, Stephen N. Crooke, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 10, pp. 2172-2188
Open Access | Times Cited: 113
Neutralizing antibodies for the treatment of COVID-19
Shibo Jiang, Xiujuan Zhang, Yang Yang, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 12, pp. 1134-1139
Open Access | Times Cited: 112
Molecular biology of coronaviruses: current knowledge
I Made Artika, Aghnianditya Kresno Dewantari, Ageng Wiyatno
Heliyon (2020) Vol. 6, Iss. 8, pp. e04743-e04743
Open Access | Times Cited: 103
The potential neurological effect of the COVID‐19 vaccines: A review
Lu Lu, Weixi Xiong, Jie Mu, et al.
Acta Neurologica Scandinavica (2021) Vol. 144, Iss. 1, pp. 3-12
Open Access | Times Cited: 99
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
Vivek P. Chavda, Radhika Pandya, Vasso Apostolopoulos
Expert Review of Vaccines (2021) Vol. 20, Iss. 12, pp. 1549-1560
Open Access | Times Cited: 95
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
Katie L. Flanagan, Emma Best, Nigel Crawford, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 94
SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen
Yunfei Wang, Lichun Wang, Han Cao, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 2, pp. 892-898
Open Access | Times Cited: 93
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
John P. Moore, Per Johan Klasse
Journal of Virology (2020) Vol. 94, Iss. 17
Open Access | Times Cited: 92
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani, Negar Firouzabadi, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108162-108162
Open Access | Times Cited: 86
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season
Chao Jiang, Xingang Yao, Yulin Zhao, et al.
Microbes and Infection (2020) Vol. 22, Iss. 6-7, pp. 236-244
Open Access | Times Cited: 84
Prospects for RNAi Therapy of COVID-19
Hasan Uludağ, Kylie Parent, Hamidreza Montazeri Aliabadi, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 79
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
Leticia Moreno‐Fierros, Ileana García-Silva, Sergio Rosales‐Mendoza
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 8, pp. 831-836
Open Access | Times Cited: 73
Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease
Tafere Mulaw Belete
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 151-161
Open Access | Times Cited: 73
Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs
Damiano Cirri, Alessandro Pratesi, Tiziano Marzo, et al.
Expert Opinion on Drug Discovery (2020) Vol. 16, Iss. 1, pp. 39-46
Open Access | Times Cited: 70
A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection
Juwairiah Remali, Wan Mohd Aizat
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 66
Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells
Kavya Rakhra, Wuhbet Abraham, Chensu Wang, et al.
Science Immunology (2021) Vol. 6, Iss. 57
Open Access | Times Cited: 61
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines
Yury Valdés-Balbín, Darielys Santana-Mederos, Françoise Paquet, et al.
ACS Central Science (2021) Vol. 7, Iss. 5, pp. 757-767
Open Access | Times Cited: 61

Scroll to top